These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34496552)

  • 41. Formulation Development and Characterization of pH Responsive Polymeric Nano-Pharmaceuticals for Targeted Delivery of Anti-Cancer Drug (Methotrexate).
    Ullah F; Iqbal Z; Khan A; Khan SA; Ahmad L; Alotaibi A; Ullah R; Shafique M
    Front Pharmacol; 2022; 13():911771. PubMed ID: 35860013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced Pharmacokinetic Activity of Zotepine via Nanostructured Lipid Carrier System in Wistar Rats for Oral Application.
    Tirumalesh C; Suram D; Dudhipala N; Banala N
    Pharm Nanotechnol; 2020; 8(2):148-160. PubMed ID: 32096755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design.
    Dhal C; Mishra R
    Drug Dev Ind Pharm; 2019 May; 45(5):805-818. PubMed ID: 30698993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formulation and Optimization of Avanafil Biodegradable Polymeric Nanoparticles: A Single-Dose Clinical Pharmacokinetic Evaluation.
    Aldawsari HM; Fahmy UA; Abd-Allah F; Ahmed OAA
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32604853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
    Nagaraj K; Narendar D; Kishan V
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formulation and optimization of celecoxib-loaded PLGA nanoparticles by the Taguchi design and their in vitro cytotoxicity for lung cancer therapy.
    Emami J; Pourmashhadi A; Sadeghi H; Varshosaz J; Hamishehkar H
    Pharm Dev Technol; 2015 Nov; 20(7):791-800. PubMed ID: 24841045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formulation and Characterization of Pyrazinamide Polymeric Nanoparticles for Pulmonary Tuberculosis: Efficiency for Alveolar Macrophage Targeting.
    Varma JN; Kumar TS; Prasanthi B; Ratna JV
    Indian J Pharm Sci; 2015; 77(3):258-66. PubMed ID: 26180270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality by Design Enabled Development of Oral Self-Nanoemulsifying Drug Delivery System of a Novel Calcimimetic Cinacalcet HCl Using a Porous Carrier: In Vitro and In Vivo Characterisation.
    Panigrahi KC; Patra CN; Rao MEB
    AAPS PharmSciTech; 2019 Jun; 20(5):216. PubMed ID: 31172322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability.
    Kaithwas V; Dora CP; Kushwah V; Jain S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():10-20. PubMed ID: 28284054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action.
    Arun JK; Vodeti R; Shrivastava B; Bakshi V
    Adv Pharm Bull; 2020 Jul; 10(3):379-388. PubMed ID: 32665896
    [No Abstract]   [Full Text] [Related]  

  • 54. Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene.
    Shah P; Rajput SJ
    Drug Dev Ind Pharm; 2019 Apr; 45(4):587-602. PubMed ID: 30633575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension.
    Pandya NT; Jani P; Vanza J; Tandel H
    Colloids Surf B Biointerfaces; 2018 May; 165():37-44. PubMed ID: 29453084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of polymeric nanoparticles with highly entrapped herbal hydrophilic drug using nanoprecipitation technique: an approach of quality by design.
    Vuddanda PR; Mishra A; Singh SK; Singh S
    Pharm Dev Technol; 2015; 20(5):579-87. PubMed ID: 24831535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
    Rafiei P; Haddadi A
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design.
    Tefas LR; Tomuţă I; Achim M; Vlase L
    Clujul Med; 2015; 88(2):214-23. PubMed ID: 26528074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aerosolizable Pyrazinamide-Loaded Biodegradable Nanoparticles for the Management of Pulmonary Tuberculosis.
    Parmar K; Sondarva S
    J Aerosol Med Pulm Drug Deliv; 2024 Feb; 37(1):30-40. PubMed ID: 38197850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.